IS6317A - Efni og lyf til að koma í veg fyrir endaþarms- og/eða ristilskrabbamein - Google Patents

Efni og lyf til að koma í veg fyrir endaþarms- og/eða ristilskrabbamein

Info

Publication number
IS6317A
IS6317A IS6317A IS6317A IS6317A IS 6317 A IS6317 A IS 6317A IS 6317 A IS6317 A IS 6317A IS 6317 A IS6317 A IS 6317A IS 6317 A IS6317 A IS 6317A
Authority
IS
Iceland
Prior art keywords
cancer
prostate
bladder
lung
epithelial cancer
Prior art date
Application number
IS6317A
Other languages
English (en)
Other versions
IS2488B (is
Inventor
Henrik Raskov Hans
Original Assignee
Colotech A/S
Henrik Raskov Hans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colotech A/S, Henrik Raskov Hans filed Critical Colotech A/S
Publication of IS6317A publication Critical patent/IS6317A/is
Publication of IS2488B publication Critical patent/IS2488B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS6317A 1999-09-29 2002-03-20 Fyrirbygging á krabbameini í ristli og endaþarmi IS2488B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901390 1999-09-29
PCT/DK2000/000546 WO2001022974A1 (en) 1999-09-29 2000-09-29 Prevention of colorectal cancer

Publications (2)

Publication Number Publication Date
IS6317A true IS6317A (is) 2002-03-20
IS2488B IS2488B (is) 2008-12-15

Family

ID=8104340

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6317A IS2488B (is) 1999-09-29 2002-03-20 Fyrirbygging á krabbameini í ristli og endaþarmi

Country Status (13)

Country Link
US (1) US7851461B2 (is)
EP (1) EP1220676B1 (is)
AT (1) ATE294585T1 (is)
AU (1) AU779996B2 (is)
CA (1) CA2385755C (is)
DE (1) DE60019947T2 (is)
DK (1) DK1220676T3 (is)
ES (1) ES2240159T3 (is)
IS (1) IS2488B (is)
NO (1) NO330061B1 (is)
NZ (1) NZ517978A (is)
PT (1) PT1220676E (is)
WO (1) WO2001022974A1 (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
ATE294585T1 (de) 1999-09-29 2005-05-15 Colotech As Vorbeugung von kolorektalkrebs
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
ES2334215T3 (es) * 2001-04-05 2010-03-08 Colotech A/S Prevencion del cancer epitelial.
WO2011024208A1 (en) * 2009-08-24 2011-03-03 Colotech A/S Combination dosage form with acetylsalicylic acid, calcitriol and calcium
EP2515913A2 (en) * 2009-12-23 2012-10-31 Glycomyr Inc. Use of vitamin d glycosides and sulfates for treatment of disease
EP2681311B1 (en) 2011-02-28 2018-03-28 Rigshospitalet, Copenhagen University Hospital Active vitamin d or analogs thereof for use in in vitro fertilization

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205025A1 (en) 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Fluorine derivatives of vitamin D3 and cell differentiation-inducing agents containing the same as an active ingredient
KR0144358B1 (ko) 1988-04-21 1998-07-15 피. 라이달 크리스텐슨 비타민 d 동족체
NZ245041A (en) 1991-11-07 1995-03-28 Res Inst Medicine Chem Vitamin d analogues and pharmaceutical compositions
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9226877D0 (en) 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
GB9309422D0 (en) 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
GB9315253D0 (en) 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
DE4334154C2 (de) 1993-10-01 1997-05-22 Schering Ag 2-Halogeno-1,25-dihydroxy-cholecalciferole und pharmazeutische Zusammensetzungen
EP0833664A1 (en) 1995-06-12 1998-04-08 G.D. SEARLE & CO. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
US5948443A (en) 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
ATE294585T1 (de) 1999-09-29 2005-05-15 Colotech As Vorbeugung von kolorektalkrebs

Also Published As

Publication number Publication date
DE60019947D1 (de) 2005-06-09
US20040116393A1 (en) 2004-06-17
NZ517978A (en) 2003-11-28
EP1220676B1 (en) 2005-05-04
AU7406300A (en) 2001-04-30
NO20021437D0 (no) 2002-03-22
CA2385755C (en) 2007-02-06
EP1220676A1 (en) 2002-07-10
ES2240159T3 (es) 2005-10-16
NO330061B1 (no) 2011-02-14
DE60019947T2 (de) 2006-02-02
IS2488B (is) 2008-12-15
US7851461B2 (en) 2010-12-14
NO20021437L (no) 2002-05-24
PT1220676E (pt) 2005-08-31
ATE294585T1 (de) 2005-05-15
WO2001022974A1 (en) 2001-04-05
AU779996B2 (en) 2005-02-24
DK1220676T3 (da) 2005-09-05
CA2385755A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
ECSP034869A (es) Una composicion para la piel, permeable selectiva inhibidora de ciclooxigenasa-2
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
SE0301700D0 (sv) Novel compounds
BR0212078A (pt) Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
DK1365808T3 (da) Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
IS6317A (is) Efni og lyf til að koma í veg fyrir endaþarms- og/eða ristilskrabbamein
CL2015001086A1 (es) Combinación farmacéutica para el tratamiento y/o quimiosensibilizacion de tumores refractarios a drogas anticancerigenas
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
PL368686A1 (en) Novel aminobenzoephenones
EA200501223A1 (ru) Терапевтическая система, содержащая амоксициллин и клавулановую кислоту
BRPI0519006A2 (pt) uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
GEP201606538B (en) Preoperative treatment of post operative pain
ATE444072T1 (de) Prävention von epithelzellkarzinom
SE0203817D0 (sv) New composition
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
AR027677A1 (es) Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación